NanoViricides
NNVC
#10122
Rank
โ‚ฌ18.82 M
Marketcap
1,05ย โ‚ฌ
Share price
-1.60%
Change (1 day)
-25.72%
Change (1 year)

NanoViricides (NNVC) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ7.1 Million

According to NanoViricides's latest financial reports the company's total assets are โ‚ฌ7.1 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

NanoViricides - Total assets on balance sheet (from 2006 to 2025)

Total assets by year

Year Total assets Change
2024-06-30โ‚ฌ11.94 M-22.86%
2023-06-30โ‚ฌ15.48 M-30.95%
2022-06-30โ‚ฌ22.42 M-12.14%
2021-06-30โ‚ฌ25.52 M19.92%
2020-06-30โ‚ฌ21.28 M79.86%
2019-06-30โ‚ฌ11.83 M-25.33%
2018-06-30โ‚ฌ15.84 M-33.03%
2017-06-30โ‚ฌ23.66 M-28.26%
2016-06-30โ‚ฌ32.98 M-16.88%
2015-06-30โ‚ฌ39.68 M23.89%
2014-06-30โ‚ฌ32.02 M154.05%
2013-06-30โ‚ฌ12.6 M2.11%
2012-06-30โ‚ฌ12.34 M66.39%
2011-06-30โ‚ฌ7.42 M3.22%
2010-06-30โ‚ฌ7.18 M238.75%
2009-06-30โ‚ฌ2.12 M127.64%
2008-06-30โ‚ฌ0.93 M-7.19%
2007-06-30โ‚ฌ1 M-53.38%
2006-06-30โ‚ฌ2.15 M
2005-06-30N/A

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.37 B 5,241.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ1.00 B 14,018.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ49.77 B 700,300.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ82.39 B 1,159,264.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ110.16 B 1,550,034.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ70.12 B 986,613.06%๐Ÿ‡ฌ๐Ÿ‡ง UK